In News

Follow this topic

Bookmark

Record learning outcomes

A Pharmacy Magazine and Thornton & Ross promotion

Up to 95 per cent of sore throats are caused by a virus¹ e.g. common cold, which can be treated without antibiotics and a trip to see a GP. Customers with a viral sore throat infection can manage their symptoms with over-the-counter medicines and self care advice. Antibiotics should only be used to treat serious bacterial infections.

For those looking to ease the pain and discomfort caused by a viral sore throat, the NHS recommends over-the-counter medicines such as medicated lozenges and anaesthetic throat sprays.²

NEW Covonia Medicated Sore Throat 5mg/1mg Lozenges have a dual action formula that numbs pain (lidocaine hydrochloride) and fights infection (chlorhexidine dihydrochloride). The lozenges are sugar-free and suitable for people with diabetes, vegetarians, vegans and coeliacs. Available in two flavours – lemon and menthol to provide soothing relief from sore throats.³

Also adding to the growing Covonia range this winter - the UK’s fastest growing throat spray⁴, Covonia Sore Throat Spray, is now available in a NEW lemon flavour. The dual action formula contains an antibacterial to fight infection (chlorhexidine gluconate) and a local anaesthetic (lidocaine hydrochloride) to numb the pain. The throat spray is sugar-free and suitable for people with diabetes, vegetarians, vegans and coeliacs. Contains up to 100 doses per 30ml spray.

COMING SOON - our POWERFUL new pharmacy training guide from Covonia on treating sore throats, incorporates practical advice for the whole pharmacy team. Pre-order your copies for the pharmacy now by emailing feelthepower@thorntonross.com

To order the NEW Covonia products please contact your Thornton & Ross representative or wholesaler:

To ‘FEEL THE POWER’ of the Covonia range visit www.covonia.co.uk and don’t forget to join the conversation on www.facebook.com/CovoniaUK, @CovoniaUK on Twitter and @Covonia_UK on Instagram.

Product Information

Covonia Medicated Sore Throat 5mg/1mg Lozenges Menthol Flavour. Contains: Chlorhexidine Dihydrochloride and Lidocaine hydrochloride. Marketing Authorisation Holder: Thornton & Ross Ltd., Linthwaite, Huddersfield, HD7 5QH, UK. Legal Classification: P. Indications: Symptomatic and local treatment at the pharynx. Information about this product, including adverse reactions, precautions, contra-indications, and method of use can be found at: https://www.medicines.org.uk/emc/product/9559

Covonia Medicated Sore Throat 5mg/1mg Lozenges Lemon Flavour. Contains: Chlorhexidine Dihydrochloride and Lidocaine hydrochloride. Marketing Authorisation Holder: Thornton & Ross Ltd., Linthwaite, Huddersfield, HD7 5QH, UK. Legal Classification: P. Indications: Symptomatic and local treatment at the pharynx. Information about this product, including adverse reactions, precautions, contra-indications, and method of use can be found at: https://www.medicines.org.uk/emc/product/9558

Covonia Sore Throat 0.2/0.05%w/v Oromucosal Spray Lemon Flavour. Contains: Chlorhexidine Gluconate and Lidocaine Hydrochloride. Marketing Authorisation Holder: Thornton & Ross Ltd., Linthwaite, Huddersfield, HD7 5QH, UK. Legal Classification: P. Indications: Symptomatic relief of painful, irritated sore throats. Information about this product, including adverse reactions, precautions, contra-indications, and method of use can be found at: https://www.medicines.org.uk/emc/product/9176

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Thornton & Ross by emailing vigilance@thorntonross.com.

References

<sub>1. Acute sore throat, Graham Worrall, MB BS MSc FCFP https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135445/
2. https://www.nhs.uk/conditions/sore-throat/ [last accessed 27th August 2019]
3. https://www.medicines.org.uk/emc/product/9559/smpc [last accessed 27th August 2019]
4. IRI 52 w/e data 15 June 2019
5. https://www.medicines.org.uk/emc/product/9176/smpc [last accessed 27th August 2019]</sub>